Vima LLC’s Aquestive Therapeutics AQST Stock Holding History

Vima LLC’s Portfolio AQST Stock Details AQST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.78K	Hold	600	–	–	﹤0.01%	314
2026 Q2	$2.5K	Buy	+600	New	+$2.52K	﹤0.01%	334

Other funds holding AQST

Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Pavaki Capital Management Pueblo, Colorado $294M AUM 34.46% 1-Year Est. Return

Sugar Maple Asset Management Sister Bay, Wisconsin $175M AUM 16.33% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return

Penbrook Management New York $169M AUM 32.52% 1-Year Est. Return

Trust Point Inc La Crosse, Wisconsin $1.33B AUM 20.56% 1-Year Est. Return

Vima LLC's AQST Position: Q3 2026 in Review

Vima LLC held its Aquestive Therapeutics (AQST) position steady in Q3 2026 at 600 shares worth $2.78K. The position accounts for ﹤0.01% of the portfolio, ranked #314.

Vima LLC first reported a position in AQST in Q2 2026 and has held it in 2 quarters since. 42 funds tracked by Wall St. Rank hold AQST as of Q3 2026.

Vima LLC held 600 shares of Aquestive Therapeutics worth $2.78K as of Q3 2026.
Vima LLC left its Aquestive Therapeutics share count unchanged in Q3 2026.
Aquestive Therapeutics made up ﹤0.01% of Vima LLC's portfolio in Q3 2026, its #314 holding.
Vima LLC first reported a position in Aquestive Therapeutics in Q2 2026 and has held it in 2 quarters since.
42 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2026.

Based on Vima LLC's 13F filing for Q3 2026, filed 23 Oct 2026.